CollPlant Biotechnologies Ltd. CLGN
NASDAQ
| 06/30/2026 | 12/31/2025 | 06/30/2025 | 03/31/2025 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 2.40M | 2.47M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 2.40M | 2.47M | |
| Cost of Revenue | -- | -- | 918.00K | 1.27M | |
| Gross Profit | -- | -- | 1.48M | 1.20M | |
| SG&A Expenses | -- | -- | 5.30M | 5.56M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | 15.74M | 17.04M | |
| Operating Income | -- | -- | -13.34M | -14.57M | |
| Income Before Tax | -- | -- | -13.00M | -13.87M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | -13.00 | -13.87 | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | -13.00M | -13.87M | |
| EBIT | -- | -- | -13.34M | -14.57M | |
| EBITDA | -- | -- | -12.37M | -13.57M | |
| EPS Basic | -- | -- | -11.26 | -12.11 | |
| Normalized Basic EPS | -- | -- | -3.88 | -4.41 | |
| EPS Diluted | -- | -- | -11.26 | -12.11 | |
| Normalized Diluted EPS | -- | -- | -3.88 | -4.41 | |
| Average Basic Shares Outstanding | -- | -- | 4.62M | 4.58M | |
| Average Diluted Shares Outstanding | -- | -- | 4.62M | 4.58M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |